4//SEC Filing
Hannah Brendan 4
Accession 0001209191-23-053695
CIK 0001662774other
Filed
Oct 25, 8:00 PM ET
Accepted
Oct 26, 5:54 PM ET
Size
5.5 KB
Accession
0001209191-23-053695
Insider Transaction Report
Form 4
Hannah Brendan
CBO, COO and CCO
Transactions
- Award
Employee Stock Option (right to buy)
2023-10-24+75,000→ 75,000 totalExercise: $0.99Exp: 2033-10-23→ Common Stock (75,000 underlying)
Footnotes (1)
- [F1]1/48th of the total number of shares subject to the option shall vest and become exercisable on each monthly anniversary of the vesting commencement date of October 23, 2023.
Documents
Issuer
Quince Therapeutics, Inc.
CIK 0001662774
Entity typeother
Related Parties
1- filerCIK 0001929422
Filing Metadata
- Form type
- 4
- Filed
- Oct 25, 8:00 PM ET
- Accepted
- Oct 26, 5:54 PM ET
- Size
- 5.5 KB